Rui Huang

No. 11 Xizhimen South Street
Xizhimen, 100044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Sarcopenic obesity in cirrhosis: prognostic value and future perspectives.

Sarcopenic obesity in cirrhosis: prognostic value and future perspectives.

Journal: Nutrition & metabolism

Published: February 24, 2026

Macro-Aspartate Aminotransferase With Metabolic Dysfunction-Associated Fatty Liver Disease in Adults:Report of One Case.

Macro-Aspartate Aminotransferase With Metabolic Dysfunction-Associated Fatty Liver Disease in Adults:Report of One Case.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: January 08, 2026

A simple score of sarcopenic obesity predicts all-cause mortality in patients with cirrhosis.

A simple score of sarcopenic obesity predicts all-cause mortality in patients with cirrhosis.

Journal: Frontiers in medicine

Published: October 07, 2025

Acute Hepatitis E Complicated With Liver Fibrosis:Report of One Case.

Acute Hepatitis E Complicated With Liver Fibrosis:Report of One Case.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: September 15, 2025

Hepatic Sinusoidal Obstruction Syndrome Secondary to Aplastic Anemia/Paroxysmal Nocturnal Hemoglobinuria Syndrome: A Rare Case.

Hepatic Sinusoidal Obstruction Syndrome Secondary to Aplastic Anemia/Paroxysmal Nocturnal Hemoglobinuria Syndrome: A Rare Case.

Journal: Diagnostics (Basel, Switzerland)

Published: September 09, 2025

Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial.

Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial.

Journal: Journal of medical virology

Published: May 25, 2025

A case of hereditary hemorrhagic telangiectasia treated with bevacizumab

A case of hereditary hemorrhagic telangiectasia treated with bevacizumab

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: March 28, 2025

Transparent and dynamic network-based risk assessment for development of hepatic encephalopathy.

Transparent and dynamic network-based risk assessment for development of hepatic encephalopathy.

Journal: Communications medicine

Published: December 19, 2024

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis.

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis.

Journal: BMC gastroenterology

Published: September 29, 2024

Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide.

Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide.

Journal: Chinese medical journal

Published: September 03, 2024

AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response.

AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response.

Journal: Diagnostics (Basel, Switzerland)

Published: July 22, 2024

Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis.

Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis.

Journal: Frontiers in medicine

Published: April 14, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026